| | | | | | | | | | |
|
|
| Dockets Entered
On August 18, 2006
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2001E-0095
|
| Vinci System, Patent Extension Application No.5,808,665
|
|
|
| 2003N-0312
|
| Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
|
|
|
| 2005N-0437
|
| Medical Gas Containers and Closures; Current Good Manufacturing
|
|
|
| 2006D-0138
|
| Guidance for Industry: Recommended Study Design and Evaluation of Effectiveness Studies for Swine Respiratory Disease Claims
|
|
|
| 2006D-0191
|
| Guidance for Industry and Food and Drug Administration; Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
| 2001E-0095
|
| Vinci System, Patent Extension Application No.5,808,665
|
|
|
| LET 3
|
| Intutitve Surgical, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2003N-0312
|
| Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
|
|
|
| EC 18
|
| Mr. Patrick Thomas
|
| Vol #:
|
| 6
|
|
|
| 2005N-0437
|
| Medical Gas Containers and Closures; Current Good Manufacturing
|
|
|
| EMC 7
|
| Tap Resources
|
| Vol #:
|
| 3
|
|
|
| 2006D-0138
|
| Guidance for Industry: Recommended Study Design and Evaluation of Effectiveness Studies for Swine Respiratory Disease Claims
|
|
|
| EMC 2
|
| Animal Health Institute
|
| Vol #:
|
| 1
|
|
|
| 2006D-0191
|
| Guidance for Industry and Food and Drug Administration; Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
|
|
|
| EC 11
|
| Cytel Inc.
|
| Vol #:
|
| 1
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
| EC 5
|
| Directed Light
|
| Vol #:
|
| 1
|
|
|
| EC 6
|
| Bilanx Consulting LLC
|
| Vol #:
|
| 1
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| EC 709
|
| Mr. Jack David Marcus
|
| Vol #:
|
| 3
|
|
|
| EC 710
|
| Ms. Carolann Peters
|
| Vol #:
|
| 3
|
|
|
| EC 711
|
| Mrs. Cheryl Taylor
|
| Vol #:
|
| 3
|
|
|
| 2006P-0223
|
| Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
|
|
|
|
|
|
| EC 1
|
| Mrs. Tammera Goley
|
| Vol #:
|
| 3
|
|
|
| EC 2
|
| Miss. Kristie Tousinau
|
| Vol #:
|
| 3
|
|
|
| EC 3
|
| Mrs. Cindi Grove
|
| Vol #:
|
| 3
|
|
|
| EC 4
|
| Dr. D. Dean Goodfellow
|
| Vol #:
|
| 3
|
|